Literature DB >> 26743829

Impact of fractionation and number of fields on dose homogeneity for intra-fractionally moving lung tumors using scanned carbon ion treatment.

Jens Wölfelschneider1, Thomas Friedrich2, Robert Lüchtenborg2, Klemens Zink3, Michael Scholz2, Lei Dong4, Marco Durante5, Christoph Bert6.   

Abstract

BACKGROUND AND
PURPOSE: Scanned particle beam therapy may result in over and under dosages within the target volume. This study quantifies how CTV dose coverage improves with number of fractions and fields.
MATERIALS AND METHODS: Based on 4DCTs of nine lung tumor patients, treatment plans were optimized separately for four different fields using an ITV approach. 4D RBE-weighted dose distributions were calculated for varying motion parameters and fraction numbers. The total RBE-weighted dose was determined for one and four-field application per fraction. DVHs were analyzed for the tumor and interpreted based on statistical modeling.
RESULTS: Dose homogeneity within the CTV increased with the fraction number, but depends significantly on the tumor motion amplitude. For single-field schedules and amplitudes >6mm, the dose coverage indices (V95min=90.7% and V107max=0.4%) differed to the stationary case even after 40 fractions. Target coverage for a four-field approach followed a proposed model and homogeneous dose distributions could be achieved 6-times faster than single-field treatments.
CONCLUSIONS: Fractionated delivery improves dose homogeneity in scanned ion beam therapy of moving targets. The achievable homogeneity depends mainly on tumor volume and motion amplitude. The outcome of multiple-field irradiations can be predicted based on single-field results and accelerates the achievement of homogeneous dose distributions.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Fractionation; Moving tumors; Particle therapy; Treatment planning

Mesh:

Substances:

Year:  2015        PMID: 26743829     DOI: 10.1016/j.radonc.2015.12.011

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  3 in total

Review 1.  Charged-particle therapy in cancer: clinical uses and future perspectives.

Authors:  Marco Durante; Roberto Orecchia; Jay S Loeffler
Journal:  Nat Rev Clin Oncol       Date:  2017-03-14       Impact factor: 66.675

2.  Assessment of robustness against setup uncertainties using probabilistic scenarios in lung cancer: a comparison of proton with photon therapy.

Authors:  Suliana Teoh; Ben George; Francesca Fiorini; Katherine A Vallis; Frank Van den Heuvel
Journal:  Br J Radiol       Date:  2020-02-04       Impact factor: 3.629

3.  AAPM Task Group Report 290: Respiratory motion management for particle therapy.

Authors:  Heng Li; Lei Dong; Christoph Bert; Joe Chang; Stella Flampouri; Kyung-Wook Jee; Liyong Lin; Michael Moyers; Shinichiro Mori; Joerg Rottmann; Erik Tryggestad; Sastry Vedam
Journal:  Med Phys       Date:  2022-01-31       Impact factor: 4.506

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.